NYSE · CCJ
Cameco financials
$86.88−0.18%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.54B | $2.19B | $1.95B | $1.38B | $1.17B | $1.41B | $1.43B | $1.54B | $1.71B | $1.81B |
| Gross profit | $920.4M | $740.9M | $590.2M | $171.9M | $1.5M | $83.6M | $185.8M | $218.0M | $346.9M | $622.0M |
| Gross margin | 36.3% | 33.9% | 30.2% | 12.5% | 0.1% | 5.9% | 13.0% | 14.1% | 20.2% | 34.3% |
| Operating income | $452.6M | $356.2M | $215.1M | $11.5M | -$104.8M | -$61.0M | $72.5M | $53.5M | -$96.0M | -$88.3M |
| Net income | $429.5M | $119.7M | $272.3M | $65.9M | -$81.2M | -$41.8M | $56.9M | $122.6M | -$163.0M | -$45.9M |
| Net margin | 16.9% | 5.5% | 13.9% | 4.8% | −7.0% | −3.0% | 4.0% | 8.0% | −9.5% | −2.5% |
| Diluted EPS | $0.99 | $0.27 | $0.63 | $0.16 | $-0.26 | $-0.11 | $0.14 | $0.31 | $-0.41 | $-0.12 |
| EBITDA | $666.2M | $551.8M | $381.4M | $142.2M | $45.9M | -$61.0M | $284.5M | $295.3M | $166.6M | $458.0M |
| Operating cash flow | $1.03B | $630.8M | $519.4M | $224.5M | $362.6M | $44.7M | $405.3M | $492.1M | $473.9M | $232.6M |
| Free cash flow | $783.5M | $483.4M | $403.4M | $118.8M | $284.4M | -$16.2M | $347.4M | $451.3M | $383.3M | $71.1M |
| Diluted shares | 435.6M | 436.0M | 435.4M | 407.1M | 397.6M | 395.8M | 396.1M | 396.1M | 395.8M | 395.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $812.3M | $418.4M | $427.8M | $842.8M | $987.0M | $721.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $19.6M |
| Total debt | $824.0M | $1.05B | $1.35B | $734.7M | $788.2M | $782.0M |
| Total assets | $7.51B | $6.90B | $7.50B | $6.36B | $5.95B | $5.96B |
| Total liabilities | $2.48B | $2.47B | $2.90B | $2.06B | $2.11B | $2.06B |
| Shareholders' equity | $5.03B | $4.43B | $4.60B | $4.30B | $3.83B | $3.90B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology